 Equitas Small Finance Bank Ltd posts PAT of Rs. 24.13 crores in Q2 FY2025-26
Equitas Small Finance Bank Ltd posts PAT of Rs. 24.13 crores in Q2 FY2025-26 Saint-Gobain Sekurit India Ltd posts Rs. 10.76 crores PAT in Q2FY26
Saint-Gobain Sekurit India Ltd posts Rs. 10.76 crores PAT in Q2FY26 Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores
Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs
ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores
Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores 
              Bombay Stock Exchange has announced that effective from Friday, July 11, 2008; the equity shares of Lotus Eye Care Hospital Limited (Scrip Code: 532998) shall be listed and admitted to dealings on the Exchange in the list of ‘B’ Group of Securities.
The equity shares of Lotus Eye Care Hospital Limited (Symbol: LOTUSEYE) shall be listed and admitted to dealings on the National Stock Exchange w.e.f. July 11, 2008. Trading shall be in the Normal Market segment – Compulsory Demat (Rolling Settlement) for all investors.
The ISIN Code of the company is INE947I01017.
The company issued shares in the recently concluded IPO at a price of Rs. 38/- per share (Face Value of Rs.10/- and premium of Rs. 28/-)
S.K.D.C Consultants Limited is the Registrar to the issue.